close
This ad will auto close in 10 seconds
Coruption is now demaned in US dollars: Kiran Mazumdar Shaw

Coruption is now demaned in US dollars: Kiran Mazumdar Shaw

While the demonetisation of Rs 500 and Rs 1000 have reportedly reduced even terror funding and corruption to a certain level, the move itself has been questioned by many.

Suresh Subramanian to head Biocon's branded formulations biz

Biotechnology major Biocon on Monday said it has appointed Suresh Subramanian as the Head of the company's branded formulations (India) business.

Licence raj replaced by time-consuming approval raj: Biocon CMD

Licence raj replaced by time-consuming approval raj: Biocon CMD

India may have created a competitive market by abolishing licence raj, but it has been replaced by an equally time-consuming "approval raj" fraught with potential corruption, Biocon CMD Kiran Mazumdar-Shaw has said.

Rajya Sabha passes bill for regional biotechnology centres

India had entered into an agreement in 2006 with UNESCO regarding establishment of Regional Centre for Biotechnology Training and Education.

JIS University to offer courses in technology, pharmacy, media

Kolkata-based JIS University announced it will soon start offering courses in technology, pharmacy, education and media.

Biocon among most reputed biotech employers globally: Survey

Biocon among most reputed biotech employers globally: Survey

Biocon Ltd Tuesday said it has earned the distinction of being the only Asian biopharma company to feature among the top biotechnology employers in the world as ranked by Science magazine.

Biocon arm Syngene appoints Peter Bains as CEO

Biotechnology major Biocon's custom research arm Syngene has appointed Peter Bains as its Chief executive Officer (CEO).

Biocon to file for Syngene unit's IPO in two months: Sources

Biotechnology firm Biocon Ltd could file a prospectus for a share listing for its research services business arm Syngene International within the next two months, two sources directly involved in the process said.

Biocon Q2 Net flat at Rs 102 crore

Biotechnology major Biocon on Wednesday reported a flat growth in its consolidated net profit at Rs 102.05 crore for the quarter ended September 30, 2014.

LIC trims stake in Biocon to 3%

State-owned LIC has cut its stake in Biocon to a little over 3 percent by selling more than two percent stake for over Rs 162 crore in the biotechnology major.

Indian biotech aiming to be $100 bn sector by 2025: Shaw

If farmers are to become prosperous you need technology, she added.

Biocon rules out listing of research services arm this fiscal

The company, which was earlier working actively to list Syngene, said it will not happen this fiscal due to economic, global and political uncertainties.

Govt drafts bill to set up Biotechnology Regulatory body

The government has drafted a bill which seeks setting up of a biotechnology regulatory authority to regulate manufacture, import and use of organisms and products of modern bio-technology.

Aus, India to jointly develop new strains of bananas

Australia`s Queensland University of Technology has inked an agreement with India`s Department of Biotechnology for developing new strains of bananas that will help counter iron-deficiency anaemia in India.